This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Magi Company Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jincheng Zou: Innovator in Tumour Immunogen Research
Introduction
Jincheng Zou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in the development of tumour immunogens. His innovative work aims to enhance the body's immune response against tumours.
Latest Patents
Jincheng Zou holds a patent for a tumour immunogen, along with its preparation method and application. The patent describes a process where localized sequential cooling-heating treatment is applied to tumour tissue and/or cells. This treatment results in the release of a substantial amount of tumour immunogen heat shock protein 70. The resulting tumour immunogen is capable of activating the body's tumour immune system, converting immunosuppressive cells into mature dendritic cells. This process increases immunogen presentation and activates tumour immunity.
Career Highlights
Jincheng Zou is associated with Magi Company Ltd., where he continues to advance his research in immunology. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Jincheng Zou collaborates with notable colleagues, including Aili Zhang and Jianqi Sun. Their combined expertise contributes to the innovative research being conducted at Magi Company Ltd.
Conclusion
Jincheng Zou is a key figure in the development of tumour immunogens, with a focus on enhancing the immune response to cancer. His contributions are paving the way for new therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile